… Breast cancer (BC) is one of the most common tumors to involve the leptomeninges. We
aimed to characterize clinical features and outcomes of patients with LMD based on BC …

… known as leptomeningeal metastases or leptomeningeal … often excluded from clinical trials
in breast cancer, with very few … strategies for patients with breast cancer and LMD. We explore …

… The metastatic spread of breast cancer to the leptomeninges … shedding into the CSF from
adjacent CNS disease [7, 8]. The … increase the risk for leptomeningeal seeding, especially if the …

… We report the treatment and outcomes of 182 breast cancer patients diagnosed with
leptomeningeal disease over a 10-year period in one single centre in the United Kingdom. Our …

… factor receptor 2 (HER2)-positive breast cancer are at a particularly high risk of breast cancer
brain metastasis (BCBM) and leptomeningeal disease (LMD). Improvements in systemic …

… Leptomeningeal metastasis (LM) in breast cancer is associated with significant morbidity …
for LM in breast cancer. We present three cases of metastatic breast cancer and LM with …

… cancer patients. The aim of this study was to identify risk factors related to survival and time
to development of LMD in breast cancer patients. A retrospective analysis of breast cancer …

Abstract Development of brain metastasis (BM) and leptomeningeal (LM) disease in breast
cancer (BC) patients indicates poor prognosis and impairs patients’ quality of life. Prognostic …

… control of breast cancer systemic disease and brain metastasis in recent decades, patients
with metastatic breast cancer are at increased risk for LMD compared to other cancers [7–10], …

… The objectives of this retrospective study were to examine a modern cohort of patients
with breast cancer diagnosed with leptomeningeal disease at Memorial Sloan Kettering …